Group 1 - The article discusses the frequent discussions of specific covered call trades within The Biotech Forum, highlighting the potential for attractive biotech stock investments [1] - Zymeworks Inc. (ZYME) is mentioned as a small-cap biotech company that was previously analyzed, with expectations for multiple upcoming FDA events [1] - The Biotech Forum, led by an experienced market analyst, offers a model portfolio of 12-20 high upside biotech stocks, along with live chat discussions and weekly research updates [1] Group 2 - The analyst has disclosed a beneficial long position in the shares of BMY and JAZZ, indicating a vested interest in these stocks [2] - The article emphasizes that past performance does not guarantee future results, and no specific investment recommendations are provided [3]
Zymeworks: A Lot Of Moving Parts (NASDAQ:ZYME)